ATE499378T1 - Anthracyclinderivate - Google Patents
AnthracyclinderivateInfo
- Publication number
- ATE499378T1 ATE499378T1 AT05733719T AT05733719T ATE499378T1 AT E499378 T1 ATE499378 T1 AT E499378T1 AT 05733719 T AT05733719 T AT 05733719T AT 05733719 T AT05733719 T AT 05733719T AT E499378 T1 ATE499378 T1 AT E499378T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosis
- anthracycline derivatives
- radiolabelled
- derivatives
- delivery system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401066A SE0401066D0 (sv) | 2004-04-22 | 2004-04-22 | Chemical Derivatives |
PCT/SE2005/000596 WO2005103065A1 (en) | 2004-04-22 | 2005-04-22 | Anthracycline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE499378T1 true ATE499378T1 (de) | 2011-03-15 |
Family
ID=32322666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05733719T ATE499378T1 (de) | 2004-04-22 | 2005-04-22 | Anthracyclinderivate |
Country Status (10)
Country | Link |
---|---|
US (2) | US20070258890A1 (de) |
EP (1) | EP1740599B1 (de) |
JP (1) | JP5156372B2 (de) |
CN (1) | CN1956992A (de) |
AT (1) | ATE499378T1 (de) |
BR (1) | BRPI0510062A (de) |
DE (1) | DE602005026510D1 (de) |
ES (1) | ES2360708T3 (de) |
SE (1) | SE0401066D0 (de) |
WO (1) | WO2005103065A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013523726A (ja) * | 2010-04-01 | 2013-06-17 | オンコレナ エービー | 腎細胞癌の改良された治療 |
CN102086219A (zh) * | 2010-11-24 | 2011-06-08 | 河南师范大学 | 具有抗癌活性的蒽环类抗生素简单结构类似物及制备方法 |
CN102146107B (zh) * | 2011-01-14 | 2014-12-31 | 河南师范大学 | (s)-2-羟烷基-1,4-二羟基-9,10-蒽醌与糖基缀合物的合成及抗肿瘤活性 |
CN113750047A (zh) * | 2020-05-28 | 2021-12-07 | 浙江大学 | 多功能纳米脂质体、制备方法及应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS539756A (en) * | 1976-07-14 | 1978-01-28 | Microbial Chem Res Found | Antitumers |
US4250303A (en) * | 1977-10-17 | 1981-02-10 | Sri International | N-Benzyl anthracyclines |
GB2007645B (en) * | 1977-10-17 | 1982-05-12 | Stanford Res Inst Int | Benzyl anthracyclines and pharmaceutical compositions containing them |
US4177264A (en) * | 1977-10-17 | 1979-12-04 | Sri International | N-benzyl anthracyclines |
CA1248944A (en) * | 1982-09-28 | 1989-01-17 | Gareth J. Thomas | Anthracycline glycosides |
US4610977A (en) * | 1985-04-08 | 1986-09-09 | The University Of Tennessee Research Corporation | N-alkyl and N-benzyl adriamycin derivatives |
DE3641833A1 (de) * | 1986-12-08 | 1988-06-09 | Behringwerke Ag | Zytostatisch wirksame anthracyclinderivate |
EP0308977B1 (de) * | 1987-09-25 | 1993-12-08 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Anthracyclin-Derivate mit Inhibitorwirkung gegen die reverse Transkriptase des menschlichen Immundefizienzvirus |
EP0971716A1 (de) * | 1996-03-22 | 2000-01-19 | Waldemar Priebe | Bis-anthracycline mit hoher wirksamkeit gegen doxorubicin resistente tumore |
AU778910B2 (en) * | 1999-03-19 | 2004-12-23 | Houston Pharmaceuticals, Inc. | Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics |
AU2002358298A1 (en) * | 2001-12-27 | 2003-07-24 | Albany Molecular Research, Inc. | Methods for preparing doxorubicin derivatives |
-
2004
- 2004-04-22 SE SE0401066A patent/SE0401066D0/xx unknown
-
2005
- 2005-04-22 BR BRPI0510062-3A patent/BRPI0510062A/pt not_active IP Right Cessation
- 2005-04-22 US US11/578,159 patent/US20070258890A1/en not_active Abandoned
- 2005-04-22 ES ES05733719T patent/ES2360708T3/es active Active
- 2005-04-22 AT AT05733719T patent/ATE499378T1/de not_active IP Right Cessation
- 2005-04-22 CN CNA2005800124959A patent/CN1956992A/zh active Pending
- 2005-04-22 JP JP2007509425A patent/JP5156372B2/ja not_active Expired - Fee Related
- 2005-04-22 EP EP05733719A patent/EP1740599B1/de not_active Not-in-force
- 2005-04-22 WO PCT/SE2005/000596 patent/WO2005103065A1/en active Application Filing
- 2005-04-22 DE DE602005026510T patent/DE602005026510D1/de active Active
-
2009
- 2009-10-13 US US12/578,380 patent/US8609135B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0510062A (pt) | 2007-10-16 |
CN1956992A (zh) | 2007-05-02 |
ES2360708T3 (es) | 2011-06-08 |
JP2007533736A (ja) | 2007-11-22 |
US8609135B2 (en) | 2013-12-17 |
SE0401066D0 (sv) | 2004-04-22 |
WO2005103065A1 (en) | 2005-11-03 |
US20100092388A1 (en) | 2010-04-15 |
EP1740599A1 (de) | 2007-01-10 |
DE602005026510D1 (en) | 2011-04-07 |
EP1740599B1 (de) | 2011-02-23 |
JP5156372B2 (ja) | 2013-03-06 |
US20070258890A1 (en) | 2007-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273765A (en) | Combinations and forms of administration of therapeutic agents and combined treatment | |
MX2009006779A (es) | Antagonistas especificos para terapia con adyuvantes y neo-adyuvantes y el tratamiento de tumores en etapa temprana. | |
RS52956B (en) | CANCER TREATMENT COMPOSITIONS | |
WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
NZ593343A (en) | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor | |
EA200801853A1 (ru) | Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток | |
TW200633700A (en) | Methods of using temozolomide formulation intrathecally in the treatment of cancers | |
DOP2009000208A (es) | Métodos de tratamiento del cáncer mediante administración de combinaciones de il-18 humana | |
WO2005113720A3 (en) | A strategy for designing patient-specific anti-cancer drugs | |
WO2005065361A3 (en) | Compounds and compositions for treating dysproliferative diseases, and methods of use thereof | |
ATE499378T1 (de) | Anthracyclinderivate | |
WO2008039994A3 (en) | Targeted photodynamic therapy agent | |
WO2011056566A3 (en) | Compounds and methods for treatment of cancer | |
WO2007008490A3 (en) | Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer | |
BRPI0810682A2 (pt) | agente antitumoral em especial para o tratamento de tumores dérmicos, fármaco, kit compreendendo fármaco. | |
WO2006069217A3 (en) | Small molecule cyclin d1 ablative agents | |
ATE537838T1 (de) | Kombinationstherapie mit kloretazin(tm) | |
IL164356A (en) | Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer | |
BRPI0409870A (pt) | uso de irinotecano para tratamento de cáncer de mama resistente | |
MXPA05008879A (es) | Una terapia combinada que comprende un derivado de indolopirrolocarbazol y otro agente antitumoral. | |
WO2009140572A3 (en) | Combinatorial treatment with glucose regulated protein-170 and melanoma differentiation associated gene-7 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |